Quality control in cervical cancer screening in the UK should target false negatives
This article was originally published in Clinica
Executive Summary
The number of false negative results detected under the UK cervical screening programme could be reduced if the focus of quality assurance systems were changed, says a new study. An investigation into why false negatives occur and how they could be reduced has found that there are quantitative differences between false negatives and true positives, according to a study in the latest issue of the Journal of Clinical Pathology (1999;52:358-62).